Document is current
Any future updates will be listed below
-
Authors
Balci, Mehmet Cihan https://orcid.org/0000-0002-3384-8679
Kor, Deniz
Yildiz, Yilmaz
Karaca, Meryem
Bulut, Fatma Derya
Kahraman, Ayca Burcu
Yesil, Alihan
Burgac, Ezgi
Ciki, Kismet
Selamioglu, Arzu
Koseci, Burcu
Durmus, Asli
Kaplan, Irem
Kara, Esra
Mungan, Halise Neslihan
Sivri, Serap
Gokcay, Gulden Fatma
Tokatli, Aysegul
Demirkol, Mubeccel
Coskun, Turgay
Ozalp, Imran
-
Funding
Funding for this research was provided by:
BioMarin Pharmaceutical
- License Information
-
More Information
Article History
Received: 21 October 2024
Accepted: 26 March 2025
First Online: 1 August 2025
Declarations
:
: Cukurova University, Faculty of Medicine, Clinical Research Ethics Committee approved the study (trial code: MON562.328.2) and related documents (19.11.2020–137/8). The protocol amendment for inclusion of SCL-90 and KBIT-2 tests as additional neurocognitive assessments, was also approved by the Ethics Committee (12.05.2022 -168/11).BU SONUÇLARA YER VERİLMEDİ AMA ANA ÇALIŞMA İLE İLİGLİ OLDUĞUNDNA KALMALI DİYE DÜŞÜNÜYORUM, The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice Guidelines. Written informed consent was obtained from all volunteers or their legal guardians after the study procedures were explained.
: Not applicable.
: The authors confirm that they do not have any potential conflict of interest. The authors confirm independence from the sponsors; the content of the article has not been influenced by the sponsors.
